Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VK2809
VK2809
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
Viking Therapeutics’ NASH Therapy Shows Major Reduction of Liver Fat and LDL Cholesterol
BioSpace
Thu, 11/19/20 - 10:27 am
Viking Therapeutics
NASH
VK2809
Here's Why Madrigal Pharmaceuticals Fell 39.4% in November
Motley Fool
Sun, 12/9/18 - 03:55 pm
Madrigal Pharmaceuticals
NASH
MGL-3196
Viking Therapeutics
VK2809
Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment
Stat
Tue, 09/18/18 - 10:00 am
Viking Therapeutics
NASH
non-alcoholic fatty liver disease
VK2809
clinical trials
3 Biotech Stocks With Big News Coming in NASH
Motley Fool
Sat, 07/14/18 - 01:11 pm
NASH
Viking Therapeutics
Gilead Sciences
Intercept Pharma
VK2809
Ocalivia
selonsertib